PATRICIA BENEDICT: Open Payments
NPI 1134455363 · RENSSELAER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,421 in 87 payments from 16 companies in 2025. Trend: 2023 $238 · 2024 $703 · 2025 $1,421
Food & beverage: $1,421
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $328 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $224 |
| Vanda Pharmaceuticals Inc. | 9 | $197 |
| Braeburn Inc. | 9 | $163 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $100 |
| Otsuka America Pharmaceutical, Inc. | 5 | $89 |
| Mallinckrodt Hospital Products Inc. | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $42 |
| Indivior Inc. | 2 | $40 |
| Amgen Inc. | 2 | $33 |
Products named: CAPLYTA, FANAPT, BRIXADI, VRAYLAR, Kerendia, REXULTI, LINZESS, ACTHAR.
Industry payments across IN — which companies pay providers there.
